<SEC-DOCUMENT>0001558370-18-004304.txt : 20180508
<SEC-HEADER>0001558370-18-004304.hdr.sgml : 20180508
<ACCEPTANCE-DATETIME>20180508161123
ACCESSION NUMBER:		0001558370-18-004304
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180508
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180508
DATE AS OF CHANGE:		20180508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARDELYX, INC.
		CENTRAL INDEX KEY:			0001437402
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36485
		FILM NUMBER:		18814659

	BUSINESS ADDRESS:	
		STREET 1:		34175 ARDENWOOD BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94555
		BUSINESS PHONE:		510-745-7047

	MAIL ADDRESS:	
		STREET 1:		34175 ARDENWOOD BLVD.
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94555

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTERYX INC
		DATE OF NAME CHANGE:	20080611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8-k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Merrill Bridge  8.0.1.3-->
<!--Created on: 5/8/2018 2:11:12 PM-->
<html>
	<head>
		<title>
			ardx_Current_Folio_8-K
		</title>
	</head>
	<body><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p style="margin:0pt;border-top:3pt solid #000000 ;border-bottom:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 9pt;">
			<font style="display:inline;font-size:9pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 18pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:18pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 18pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:18pt;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Washington, D.C. 20549</font>
		</p>
		<p style="margin:0pt 0pt 10pt;border-bottom:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 18pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:18pt;">FORM 8-K</font>
		</p>
		<p style="margin:0pt 0pt 10pt;border-bottom:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">CURRENT REPORT</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Pursuant to Section&nbsp;13 or 15(d)</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">of the Securities Exchange Act of 1934</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Date of Report (Date of earliest event reported): May 8, 2018</font>
		</p>
		<p style="margin:0pt 0pt 10pt;border-bottom:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 24pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:24pt;">ARDELYX, INC.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">(Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt 0pt 10pt;border-bottom:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:33.40%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">Delaware</font></p>
				</td>
				<td valign="top" style="width:33.30%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">001-36485</font></p>
				</td>
				<td valign="top" style="width:33.30%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">26-1303944</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:33.40%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(State or other jurisdiction<br />of incorporation)</font></p>
				</td>
				<td valign="top" style="width:33.30%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(Commission<br />File Number)</font></p>
				</td>
				<td valign="top" style="width:33.30%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(IRS Employer<br />Identification Number)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">34175 Ardenwood Blvd., Suite 200</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Fremont, CA 94555</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
			<font style="display:inline;font-weight:bold;font-size:8pt;">(Address of principal executive offices, including Zip Code)</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Registrant&#x2019;s telephone number, including area code: (510)&nbsp;745-1700</font>
		</p>
		<p style="margin:0pt 0pt 10pt;border-bottom:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:03.22%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Segoe UI Symbol;">&#x2610;</font></p>
				</td>
				<td valign="bottom" style="width:96.78%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:03.22%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Segoe UI Symbol;">&#x2610;</font></p>
				</td>
				<td valign="bottom" style="width:96.78%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:03.22%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Segoe UI Symbol;">&#x2610;</font></p>
				</td>
				<td valign="bottom" style="width:96.78%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:03.22%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Segoe UI Symbol;">&#x2610;</font></p>
				</td>
				<td valign="bottom" style="width:96.78%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter).</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Emerging growth company&nbsp;&nbsp;</font><font style="display:inline;font-family:Segoe UI Symbol;">&#x2612;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;</font><font style="display:inline;font-family:Segoe UI Symbol;">&#x2612;</font>
		</p>
		<p style="margin:0pt;border-top:1pt solid #000000 ;border-bottom:3pt solid #000000 ;font-family:Times New Roman,Times,serif;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			&nbsp;
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Item&nbsp;2.02</font><font style="display:inline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Results of Operations and Financial Condition. </font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">On May&nbsp;8, 2018, Ardelyx, Inc. (the &#x201C;Company&#x201D;) announced its financial results for the quarter ended March 31, 2018. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">The information furnished under this Item 2.02 shall not be considered &#x201C;filed&#x201D; under the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or under&nbsp;the Securities Exchange Act of 1934, as amended, unless the Company expressly sets forth in such future filing that such information is to be considered &#x201C;filed&#x201D; or incorporated by reference therein.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Item&nbsp;9.01</font><font style="display:inline;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Financial Statements and Exhibits. </font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">(d) Exhibits.</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:07.04%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Exhibit<br />No.</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:90.90%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:07.04%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">99.1</font></p>
				</td>
				<td valign="bottom" style="width:02.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:90.90%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;"><a href="ex-99d1.htm">Press release of Ardelyx, Inc.</a></font><font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
			<font style="display:inline;font-size:11pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 8pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">SIGNATURES</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:242.60pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Date: May 8, 2018</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:242.70pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">ARDELYX, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:242.60pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:242.70pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:242.60pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:18.40pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">By:</font></p>
				</td>
				<td valign="bottom" style="width:224.30pt;border-bottom:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">/s/ Mark Kaufmann</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:242.60pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:18.40pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:224.30pt;border-top:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Mark Kaufmann</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:242.60pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:18.40pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:224.30pt;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Chief Financial Officer</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Merrill Bridge  8.0.1.3-->
<!--Created on: 5/8/2018 2:11:11 PM-->
<html>
	<head>
		<title>
			ardx_Ex99_1
		</title>
	</head>
	<body><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><div style="width:100%">

		<p style="margin:0pt 0pt 15pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">

			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Exhibit 99.1</font>

		</p>

		<p style="margin:0pt 0pt 15pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;"><img src="ex-99d1g001.jpg" style="width: 1.697522in; height: 0.4in" alt="Picture 3"></font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 14pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:14pt;">Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">On Track to Submit NDA for Tenapanor in IBS-C in Second Half of 2018</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-style:italic;font-size:12pt;">Enrollment Underway in Second Registration Study of Tenapanor for Hyperphosphatemia</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">FREMONT, Calif., May 8, 2018</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> -- Ardelyx, Inc. (NASDAQ: ARDX), today reported business highlights and financial results for the first quarter ended March 31, 2018.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&#x201C;The first quarter of 2018 has been about execution for Ardelyx,&#x201D; said Mike Raab, president and chief executive officer of Ardelyx. "We are focused on enrolling our second Phase 3 study for tenapanor for hyperphosphatemia and investigating the potential of our RDX013 program for the treatment of hyperkalemia. In addition, our team is preparing the NDA submission for tenapanor for IBS-C, which, when submitted, will be a landmark milestone for our company. We now have three strategic collaborations in place that will enable us to bring tenapanor to patients in geographies outside of the U.S., positioning us to be able to meaningfully impact the care of many patients."</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Recent Business and Pipeline Updates</font>
		</p>
		<p style="margin:0pt 0pt 10pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:12pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">On Track to Submit NDA for Tenapanor for IBS-C in 2H 2018: </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Following the successful completion of the T3MPO program in late 2017, Ardelyx is on-track to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tenapanor for irritable bowel syndrome with constipation (IBS-C) in the second half of 2018. The Phase 3 T3MPO program was designed to support the registration of tenapanor for the treatment of IBS-C.</font>
		</p>
		<p style="margin:0pt 0pt 10pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:12pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Patient Enrollment Underway in Second Phase 3 Clinical Trial of Tenapanor for Hyperphosphatemia:</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> In February 2018, Ardelyx began treating patients in the Phreedom Trial, the company's second Phase 3 clinical trial of tenapanor for the treatment of hyperphosphatemia in patients with end-stage renal disease who are on dialysis. This clinical trial includes a 26-week open-label treatment period, with a 12-week placebo-controlled randomized withdrawal period followed by an additional 14-week open-label safety extension period for a total of up to 52 weeks. An active control group, for safety analysis only and consistent with other Phase 3 registration studies for hyperphosphatemia, will receive sevelamer, open-label, for the entire 52-week study period. Ardelyx currently expects to report topline data from this clinical trial in 2019.</font>
		</p>
		<p style="margin:0pt 0pt 10pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:12pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Knight Therapeutics Agreement Brings Tenapanor for IBS-C and Hyperphosphatemia to Canada:</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;"> A license agreement with Knight Therapeutics, Inc. (Knight), signed in March 2018, provides Knight with exclusive rights to commercialize tenapanor in Canada for the treatment of IBS-C and hyperphosphatemia. Under the terms of the agreement, Ardelyx is eligible to receive up to CAD 25 million in total payments, including an upfront payment and development and sales milestones, as well as double-digit tiered royalties on net sales. Knight will have the exclusive rights to market and sell tenapanor in Canada.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			&nbsp;
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Upcoming Digestive Disease Week Presentations</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Ardelyx has been selected to give an oral presentation of its Phase 3 T3MPO-2 trial results for tenapanor for the treatment of IBS-C in the clinical sciences late-breaking plenary session. &nbsp;The company is also presenting three posters. Ardelyx will present preclinical data from the company&#x2019;s APECCS platform demonstrating tenpanor&#x2019;s pain mechanism, preclinical data from its RDX-023 FXR agonist program showing reduction in steatosis, inflammation and fibrosis in three mouse models of NASH, as well as preclinical data from the RDX-011 NHE3 program showing normalization of GI transit in models of opioid-induced constipation, multiple sclerosis and cystic fibrosis. &nbsp;Digestive Disease Week is being held June 2-5, 2018 in Washington D.C.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">First Quarter 2018 Financial Results</font>
		</p>
		<p style="margin:0pt 0pt 10pt 41.75pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:11pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Cash Position</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">: As of March 31, 2018, Ardelyx had total capital resources including cash, cash equivalents and short-term investments of $127.4 million compared to total capital resources including cash, cash equivalents and short-term investments of $134.0 million as of December 31, 2017.</font>
		</p>
		<p style="margin:0pt 0pt 10pt 41.75pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:11pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Revenue</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">: Licensing revenue for the&nbsp;quarter ended March 31, 2018 was $2.3 million, related to the recognition of revenue from licensing activities. The company generated no license revenue for the&nbsp;quarter ended March 31, 2017.</font>
		</p>
		<p style="margin:0pt 0pt 10pt 41.75pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:11pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Cost of Revenue</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">: Cost of revenue for the&nbsp;quarter ended March 31, 2018 was $0.5 million representing license payments due to AstraZeneca in accordance with the company&#x2019;s termination agreement entered into with AstraZeneca in June 2015. The company generated no revenue for the&nbsp;quarter ended March 31, 2017 and therefore had no cost of revenue.</font>
		</p>
		<p style="margin:0pt 0pt 10pt 41.75pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:11pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">R&amp;D Expenses</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">: Research and development expenses were $13.4 million for the three months ended March 31, 2018, a decrease of $9.0 million, or 40 percent, compared to $22.4 million for the three months ended March 31, 2017. The decrease consisted of a $7.0 million decrease in external program costs primarily related to a decrease in expenses incurred for clinical development activities related to the completion of some of the company&#x2019;s Phase 3 clinical trials for tenapanor, offset partially by an increase from the start of the company&#x2019;s hyperphosphatemia Phase 3 study, &nbsp;discontinuation of the RDX7675 program and reduction of activities associated with the company&#x2019;s RDX8940 program. The $9.0 million decrease further included a $2.0 million decrease in internal program costs, primarily due to a decrease in salaries and related costs, including stock-based compensation costs, resulting from a reduction in work force during the third quarter of 2017.</font>
		</p>
		<p style="margin:0pt 0pt 10pt 41.75pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:11pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">G&amp;A Expenses</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">: General and administrative expenses were $6.2 million for the three months ended March 31, 2018, an increase of $0.2 million, or 2 percent, compared to $6.0 million for the three months ended March 31, 2017, remaining relatively flat. The increase was primarily due to increases in stock-based compensation expense, partially offset by a reduction in salaries and related costs due to reduction in work force during the third quarter of 2017.</font>
		</p>
		<p style="margin:0pt 0pt 0pt 41.75pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Symbol;">&#xF0B7;<font style="display:inline;font-family:Symbol;;font-size: 12pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 11.4pt 0pt 0pt;"></font></font><font style="display:inline;font-family:Symbol;font-size:11pt;"></font><font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Net Loss</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">: Net loss for the quarter ended March 31, 2018, was $17.0 million compared to a net loss of $28.0 million for the quarter ended March 31, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:24pt 0pt 0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">2</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">About Ardelyx, Inc.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Ardelyx&nbsp;is focused on enhancing the way people with renal diseases are treated by developing first-in-class medicines.&nbsp;Ardelyx's&nbsp;renal pipeline includes the Phase 3 development of tenapanor for the treatment of hyperphosphatemia in people with end-stage renal disease who are on dialysis and RDX013, a potassium secretagogue program for the potential treatment of high potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease. In addition,&nbsp;Ardelyx&nbsp;has completed Phase 3 development of tenapanor for the treatment of irritable bowel syndrome with constipation and anticipates submitting a New Drug Application to the&nbsp;U.S. Food and Drug Administration&nbsp;for this indication in the second half of 2018. To efficiently bring its treatments to market,&nbsp;Ardelyx&nbsp;is pursing strategic collaborations in the U.S. and outside the U.S., with established agreements with&nbsp;Kyowa Hakko Kirin&nbsp;in&nbsp;Japan, Fosun Pharma in&nbsp;China&nbsp;and&nbsp;Knight Therapeutics&nbsp;in&nbsp;Canada. For more information, please visit&nbsp;http://www.ardelyx.com/&nbsp;and connect with us on Twitter @Ardelyx.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Forward Looking Statements</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">To the extent that statements contained in this press release are not descriptions of historical facts regarding Ardelyx, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor of the Private Securities Reform Act of 1995, including the potential for Ardelyx&#x2019;s product candidates in treating the diseases and conditions for which they are being developed; Ardelyx&#x2019;s expected timing for the filing of its NDA for tenapanor for the treatment of IBS-C, Ardelyx&#x2019;s expected timing to report topline data for its second Phase 3 clinical trial of tenapanor for the treatment of hyperphosphatemia in patients with end-stage renal disease who are on dialysis, the potential for Ardelyx to receive milestone and royalty payments from Knight Therapeutics and Ardelyx&#x2019;s ability to establish collaborations in the future. Such forward-looking statements involve substantial risks and uncertainties that could cause the development of Ardelyx&#x2019;s product candidates or Ardelyx&#x2019;s future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in research and the clinical development process, including the regulatory approval process. Ardelyx undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ardelyx&#x2019;s business in general, please refer to Ardelyx&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 14, 2018, and its future current and periodic reports to be filed with the Securities and Exchange Commission.</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">###</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Contacts:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Monique Allaire, THRUST IR</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">781-631-0759</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">monique@thrustir.com</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">OR</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">Alicia Davis, THRUST IR</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">910-620-3302</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">alicia@thrustir.com</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:24pt 0pt 0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">3</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Ardelyx, Inc.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Condensed Consolidated Balance Sheets</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">(In thousands)</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;background-color: #FFFFFF;">
			<tr>
				<td valign="bottom" style="width:74.24%;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.42%;border-bottom:1pt solid #000000 ;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">March&nbsp;31,<br />2018</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.62%;border-bottom:1pt solid #000000 ;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">December&nbsp;31,<br />2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.24%;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.42%;border-top:1pt solid #000000 ;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">(Unaudited)</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.62%;border-top:1pt solid #000000 ;background-color: #FFFFFF;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">(1)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Assets</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Cash and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">67,745&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">75,383&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Short-term investments</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-indent:30pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">59,704&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">58,593&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Accounts receivable</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">10,796&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Unbilled license revenue</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">5,000&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">7,358&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">8,032&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Prepaid and other assets</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">3,030&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">5,099&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Total assets</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">142,837&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">157,903&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;border-top:2pt double #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;border-top:2pt double #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Liabilities and stockholders&#x2019; equity</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Accounts payable and other current liabilities</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">12,162&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">17,871&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Uncharged license fees</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">1,000&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Long-term liabilities</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">699&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">720&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 21.6pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Stockholders&#x2019; equity </font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">128,976&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">139,312&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="middle" style="width:74.24%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Total liabilities and stockholders&#x2019; equity </font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.06%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.36%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">142,837&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.08%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.54%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">157,903&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<div><hr style="border-width:0;width:25%;height:1pt;color:#000;background-color:#000;" align="left"></hr></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">(1)&nbsp;&nbsp;&nbsp;&nbsp;Derived from the audited consolidated financial statements included on Form 10-K for the year ended December 31, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:24pt 0pt 0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">4</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			&nbsp;

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Ardelyx, Inc.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Condensed Consolidated Statements of Operations</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">(In thousands, except share and per share amounts)</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;">
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.78%;border-bottom:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.22%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">2018</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.22%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;background-color: #auto;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.22%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">(Unaudited)</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.22%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:8pt;">(Unaudited)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Revenue:</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 28.8pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Licensing revenue</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">2,320&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Cost of revenue</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">464&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 28.8pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Gross profit</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">1,856&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Operating expenses:</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 28.8pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">13,350&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">22,387&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 28.8pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">6,191&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">6,047&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Total operating expenses</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">19,541&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">28,434&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Loss from operations</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(17,685)
				</td>
				<td valign="bottom" style="width:02.34%;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28,434)
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Other income</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">670&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">426&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Provision for income taxes</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-bottom:1pt solid #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4)
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&#x2014;&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 14.4pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Net loss</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-bottom:2pt double #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(17,019)
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28,008)
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Net loss per common share, basic &amp; diluted</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:2pt double #000000 ;border-bottom:2pt double #000000 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(0.36)
				</td>
				<td valign="bottom" style="width:02.34%;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">$</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(0.59)
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 7.2pt;text-indent: -7.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">Shares used in computing net loss per share, basic and diluted</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:2pt double #000000 ;border-bottom:2pt double #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">47,559,366&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;border-top:2pt double #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:11.06%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">47,343,234&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:24pt 0pt 0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">

			<font style="display:inline;">5</font>

		</p>

</div></div><div style="margin-left:5.88235294117647%;margin-right:5.88235294117647%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex-99d1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex-99d1g001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #S! 0# 2(  A$! Q$!_\0
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M%U/9\YI:I6=S'<PK-"P*$9/-606+<]*X9+E-TTR2BD4YS3J2=P$I!]ZEHHN
MU@2U5;^\%I"SGH!UJV:QO$7_ "!IJI(ELXV?XHV4,\D923*M@U'_ ,+6L?\
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M$ <UV4*:EH8U&T>G'XIV;1;@DG6D_P"%I6.1F.2O&B<1X!.,TU6+2#GM7HK
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M->;?#7P]]ET_[5*OS3*#S7I$2".,*.U>;5BHRLCK@[H?1116184444 %%%%
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M?Q$=FDR@>E:D+B1$8=U!K*\1C.FR?2O%BO>L=CV/FC4?^0C<?]=#5:K.H_\
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M/!VH:4[#R7DC/\>.!7.&)H\J3DCJ*]*%2,D<S@T1H01R<FCYL\G\*,[>B8-
M)(R1@UKS/H#7<7 SR*7@<J,'VI**A\KW0E*VQJZ9X@O].D#17,@ _A!KTWPW
M\3[=]L.H!(^V]C7CF.<GBG,$E'3!]:Y:F%A/9&T:LCZFL-:M-00-:S+*#Z5H
M9ZU\QZ1XGO\ 17402.RCLM>G>'OB7%=%(KO$;'@EC7GU\'*&QO&I<V_B&/\
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M5QQ0,@=*)5W)%JG809P 13Q]Z@<#)H7GFN=HTM8?1110 4444 &*3 ]*6B@
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M)FX'AA^%>I;\^4VWZTO_  JR_P#^>;?G7N(3GK3]E:+&,GV5SPO_ (59?_\
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!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
